FI884088A0 - Foerfarande foer framstaellning av 17-substituerade androsta-1,4-dien-3-onderivat. - Google Patents

Foerfarande foer framstaellning av 17-substituerade androsta-1,4-dien-3-onderivat.

Info

Publication number: FI884088A0
Authority: FI; Finland
Prior art keywords: alkyl; hydrogen; androsta; onderivat; substituerade
Prior art date: 1987-09-11

Application number

FI884088A

Other languages

English (en)

Other versions

FI88393B (fi

FI884088A (fi

FI88393C (fi

Inventor

Vittoria Villa

Salle Enrico Di

Paolo Lombardi

Original Assignee

Erba Carlo Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-09-11

Filing date

1988-09-06

Publication date

1988-09-06

1988-09-06 Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa

1988-09-06 Publication of FI884088A0 publication Critical patent/FI884088A0/fi

1989-03-12 Publication of FI884088A publication Critical patent/FI884088A/fi

1993-01-29 Publication of FI88393B publication Critical patent/FI88393B/fi

1993-05-10 Application granted granted Critical

1993-05-10 Publication of FI88393C publication Critical patent/FI88393C/fi

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

FI884088A 1987-09-11 1988-09-06 Foerfarande foer framstaellning av 17-substituerade androsta-1,4-dien-3-onderivat FI88393C (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB8721384		1987-09-11
GB878721384A GB8721384D0 (en)	1987-09-11	1987-09-11	17-substituted andro-sta-1 4-dien-3-one derivatives

Publications (4)

Publication Number	Publication Date
FI884088A0 true FI884088A0 (fi)	1988-09-06
FI884088A FI884088A (fi)	1989-03-12
FI88393B FI88393B (fi)	1993-01-29
FI88393C FI88393C (fi)	1993-05-10

Family

ID=10623619

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI884088A FI88393C (fi)	1987-09-11	1988-09-06	Foerfarande foer framstaellning av 17-substituerade androsta-1,4-dien-3-onderivat

Country Status (14)

Country	Link
US (1)	US4873233A (fi)
EP (1)	EP0307135B1 (fi)
JP (1)	JP2677626B2 (fi)
KR (1)	KR970007948B1 (fi)
AT (1)	ATE79629T1 (fi)
AU (1)	AU602607B2 (fi)
CA (1)	CA1305699C (fi)
DE (1)	DE3873862T2 (fi)
ES (1)	ES2043834T3 (fi)
FI (1)	FI88393C (fi)
GB (1)	GB8721384D0 (fi)
GR (1)	GR3005961T3 (fi)
IL (1)	IL87656A (fi)
SU (1)	SU1750431A3 (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH683151A5 (de) *	1991-04-24	1994-01-31	Ciba Geigy Ag	Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
FR2681069B1 (fr) *	1991-09-06	1995-04-28	Roussel Uclaf	Nouveau procede de preparation de l'hydrocortisone et nouveaux intermediaires.
GB9201224D0 (en) *	1992-01-21	1992-03-11	Erba Carlo Spa	Difluoromethylenandrostenone derivatives and process for their preparation
GB9217035D0 (en) *	1992-08-11	1992-09-23	Erba Carlo Spa	Androst-4-eno(4,5-b)pyrrole derivatives and process for their preparation
CA2118317A1 (en) *	1993-02-18	1994-09-01	Pharmacia S.P.A.	Fluorinated 4-aminoandrostadienone derivatives and process for their preparation
DE10104327A1 (de) *	2001-01-24	2002-07-25	Schering Ag	11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
MXPA04003405A (es) *	2001-10-10	2004-06-18	Pharmacia Italia Spa	Metodos para prevenir y tratar la perdida de hueso con compuestos esteroidales.
US7435757B2 (en) *	2004-07-02	2008-10-14	Schering Ag	2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1
US20060211667A1 (en) *	2005-03-21	2006-09-21	Eric Marchewitz	Use of pregnane steroid derivatives for enhancing physical performance
EP1854465A1 (en) *	2006-05-12	2007-11-14	Alexander Tobias Teichmann	Use of 4,17 beta-dihydroxyandrost-4-ene-3-one for treating cancers
ES2574933T3 (es) *	2007-11-13	2016-06-23	Athenion Ag	Esteroides de C-19 para usos cosméticos
DK2060300T3 (da)	2007-11-13	2015-06-22	Curadis Gmbh	C-19-steroider til terapeutiske anvendelser

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB929985A (fi) *
GB8517360D0 (en) *	1985-07-09	1985-08-14	Erba Farmitalia	Substituted androsta-1,4-diene-3,17-diones

1987
- 1987-09-11 GB GB878721384A patent/GB8721384D0/en active Pending
1988
- 1988-09-01 DE DE8888308104T patent/DE3873862T2/de not_active Expired - Fee Related
- 1988-09-01 AT AT88308104T patent/ATE79629T1/de not_active IP Right Cessation
- 1988-09-01 EP EP88308104A patent/EP0307135B1/en not_active Expired - Lifetime
- 1988-09-01 ES ES88308104T patent/ES2043834T3/es not_active Expired - Lifetime
- 1988-09-02 IL IL87656A patent/IL87656A/xx not_active IP Right Cessation
- 1988-09-06 FI FI884088A patent/FI88393C/fi active IP Right Grant
- 1988-09-07 AU AU21979/88A patent/AU602607B2/en not_active Ceased
- 1988-09-08 JP JP63225509A patent/JP2677626B2/ja not_active Expired - Fee Related
- 1988-09-09 CA CA000576898A patent/CA1305699C/en not_active Expired - Fee Related
- 1988-09-09 SU SU884356448A patent/SU1750431A3/ru active
- 1988-09-09 KR KR1019880011642A patent/KR970007948B1/ko not_active IP Right Cessation
- 1988-09-12 US US07/242,855 patent/US4873233A/en not_active Expired - Lifetime
1992
- 1992-10-12 GR GR920402284T patent/GR3005961T3/el unknown

Also Published As

Publication number	Publication date
KR890005142A (ko)	1989-05-13
DE3873862D1 (de)	1992-09-24
ES2043834T3 (es)	1994-01-01
EP0307135A1 (en)	1989-03-15
DE3873862T2 (de)	1993-01-14
CA1305699C (en)	1992-07-28
JP2677626B2 (ja)	1997-11-17
JPH01104096A (ja)	1989-04-21
AU602607B2 (en)	1990-10-18
ATE79629T1 (de)	1992-09-15
EP0307135B1 (en)	1992-08-19
IL87656A0 (en)	1989-02-28
GB8721384D0 (en)	1987-10-21
IL87656A (en)	1993-02-21
FI88393B (fi)	1993-01-29
FI884088A (fi)	1989-03-12
AU2197988A (en)	1989-03-16
GR3005961T3 (fi)	1993-06-07
KR970007948B1 (ko)	1997-05-19
SU1750431A3 (ru)	1992-07-23
US4873233A (en)	1989-10-10
FI88393C (fi)	1993-05-10

Legal Events

Date	Code	Title	Description
1993-01-04	BB	Publication of examined application
1996-11-29	PC	Transfer of assignment of patent	Owner name: PHARMACIA & UPJOHN S.P.A.
2004-08-31	FG	Patent granted	Owner name: PHARMACIA ITALIA S.P.A.

Publication	Publication Date	Title
DE68906552T2 (de)	1993-12-16	Camptothecin-Derivate und Verfahren zu ihrer Herstellung.
FI965020A (fi)	1996-12-16	Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita
DK0565377T3 (da)	1998-03-16	Terapeutiske midler til behandling af Parkinsons sygdom
FI884088A0 (fi)	1988-09-06	Foerfarande foer framstaellning av 17-substituerade androsta-1,4-dien-3-onderivat.
DK0390654T3 (da)	1995-04-03	Aminobenzensulfonsyrederivater
NO872892D0 (no)	1987-07-10	Fremgangsmaate ved fremstilling av nye 6- eller 7-metylenandrosta-1,4 dien-3,17-dion-derivater.
ES2012648A6 (es)	1990-04-01	Procedimiento para la preparacion de nuevos derivados de 1,4-benzoxazina y 1,4-benzotiazina.
ES2169220T3 (es)	2002-07-01	Derivados de vitamina d3 con sustituyentes en la posicion 2.
ATE168367T1 (de)	1998-08-15	Vitamin-d-derivate und verfahren zu deren herstellung
NZ216922A (en)	1989-07-27	6-amino-androsta-1,4-diene-3,17-dione derivatives and pharmaceutical compositions